234 related articles for article (PubMed ID: 10782769)
1. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.
Capizzano AA; Schuff N; Amend DL; Tanabe JL; Norman D; Maudsley AA; Jagust W; Chui HC; Fein G; Segal MR; Weiner MW
AJNR Am J Neuroradiol; 2000 Apr; 21(4):621-30. PubMed ID: 10782769
[TBL] [Abstract][Full Text] [Related]
2. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
3. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.
Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW
Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
[TBL] [Abstract][Full Text] [Related]
5. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
Constans JM; Meyerhoff DJ; Gerson J; MacKay S; Norman D; Fein G; Weiner MW
Radiology; 1995 Nov; 197(2):517-23. PubMed ID: 7480705
[TBL] [Abstract][Full Text] [Related]
6. Early- and late-state subacute sclerosing panencephalitis: chemical shift imaging and single-voxel MR spectroscopy.
Alkan A; Sarac K; Kutlu R; Yakinci C; Sigirci A; Aslan M; Baysal T
AJNR Am J Neuroradiol; 2003 Mar; 24(3):501-6. PubMed ID: 12637304
[TBL] [Abstract][Full Text] [Related]
7. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR
Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
9. Applying functional MR imaging to brain-behavioral research: can we do better than simple clinical measures?
George AE; Cha S
AJNR Am J Neuroradiol; 2000 Apr; 21(4):619-20. PubMed ID: 10782768
[No Abstract] [Full Text] [Related]
10. Effects of white matter lesions and lacunes on cortical function.
Reed BR; Eberling JL; Mungas D; Weiner M; Kramer JH; Jagust WJ
Arch Neurol; 2004 Oct; 61(10):1545-50. PubMed ID: 15477508
[TBL] [Abstract][Full Text] [Related]
11. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
Auer DP; Schirmer T; Heidenreich JO; Herzog J; Pütz B; Dichgans M
Neurology; 2001 Mar; 56(5):635-42. PubMed ID: 11245716
[TBL] [Abstract][Full Text] [Related]
12. Developmental delay in children: assessment with proton MR spectroscopy.
Filippi CG; Uluğ AM; Deck MD; Zimmerman RD; Heier LA
AJNR Am J Neuroradiol; 2002 May; 23(5):882-8. PubMed ID: 12006297
[TBL] [Abstract][Full Text] [Related]
13. Subcortical gray matter N-acetylaspartate reduction in two cases of vascular dementia.
Ben Salem D; Walker PM; Osseby GV; Krausé D; Giroud M; Brunotte F
Clin Imaging; 2003; 27(1):14-7. PubMed ID: 12504314
[TBL] [Abstract][Full Text] [Related]
14. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
Reneman L; Majoie CB; Flick H; den Heeten GJ
AJNR Am J Neuroradiol; 2002 Feb; 23(2):231-7. PubMed ID: 11847047
[TBL] [Abstract][Full Text] [Related]
15. 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment.
Gasparovic C; Prestopnik J; Thompson J; Taheri S; Huisa B; Schrader R; Adair JC; Rosenberg GA
J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):715-21. PubMed ID: 23418212
[TBL] [Abstract][Full Text] [Related]
16. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker.
Watanabe H; Fukatsu H; Katsuno M; Sugiura M; Hamada K; Okada Y; Hirayama M; Ishigaki T; Sobue G
J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):103-9. PubMed ID: 14707317
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.
Fein G; Di Sclafani V; Tanabe J; Cardenas V; Weiner MW; Jagust WJ; Reed BR; Norman D; Schuff N; Kusdra L; Greenfield T; Chui H
Neurology; 2000 Dec; 55(11):1626-35. PubMed ID: 11113215
[TBL] [Abstract][Full Text] [Related]
18. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
[TBL] [Abstract][Full Text] [Related]
19. Severe metabolic abnormalities in the white matter of patients with vacuolating megalencephalic leukoencephalopathy with subcortical cysts. A proton MR spectroscopic imaging study.
De Stefano N; Balestri P; Dotti MT; Grosso S; Mortilla M; Morgese G; Federico A
J Neurol; 2001 May; 248(5):403-9. PubMed ID: 11437163
[TBL] [Abstract][Full Text] [Related]
20. Neuronal metabolic changes in the cortical region after subcortical infarction: a proton MR spectroscopy study.
Kang DW; Roh JK; Lee YS; Song IC; Yoon BW; Chang KH
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):222-7. PubMed ID: 10896697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
